- $51.22bn
- $50.13bn
- $71.05bn
- 79
- 85
- 62
- 89
Annual balance sheet for Metlife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-Q | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,614 | 2,210 | — | 3,561 | 3,528 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Deferred Policy Acquisition Costs | |||||
Total Other Assets | |||||
Total Assets | 795,146 | 759,708 | 663,072 | 687,584 | 677,457 |
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 720,588 | 692,226 | 633,191 | 657,569 | 650,012 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 74,558 | 67,482 | 29,881 | 30,015 | 27,445 |
Total Liabilities & Shareholders' Equity | 795,146 | 759,708 | 663,072 | 687,584 | 677,457 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |